Genetic risk of DNA repair gene polymorphisms (XRCC1 and XRCC3) for high risk human papillomavirus negative cervical cancer in Northeast Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 4, 2011, Pages 963-966

  Settheetham Ishida, Wannapa ^a   Yuenyao, Pissamai ^a   Natphopsuk, Sitakan ^b   Settheetham, Dariwan ^c   Ishida, Takafumi ^d  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c UNIVERSITY OF TOKYO   (Japan)

^d NONE

Author keywords

Cervical cancer; DNA repair genes; Genetic risk; Non HPV; Northeast Thailand

Indexed keywords

EID: 84856250695     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Au WW, Navasumrit P, Ruchirawat M (2004). Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health, 207, 301-13.
2. Cote M, Yoo W, Wenzlaff A, et al (2009). Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis, 30, 626-35.
3. Goode EL, Ulrich CM, Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
4. He X, Ye F, Zhang J, et al (2008). Susceptibility of XRCC3, XPD, and XPG genetic variants to cervical carcinoma. Pathobiology, 75, 356-63.
5. Huang J, Ye F, Chen H, et al (2007). The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection. Int J Gynecol Cancer, 17, 668-75.
6. Khuhaprema T, Srivatanakul P, Attasara P, et al (2010). Cancer in Thailand, Volume V, 2001-2003. National Cancer Institute, Ministry of Public Health, Thailand.
7. Mathonnet G, Labuda D, Meloche C, et al (2003). Variable continental distribution of polymorphisms in the coding regions of DNA-repair genes. J Hum Genet, 48, 659-64.
8. McCann MF, Irwin DE, Walton LA, et al (1992). Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev, 1, 125-9.
9. Niwa Y, Matsuo K, Ito H, et al (2005). Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. Gynecol Oncol, 99, 43-9.
10. Pryor WA, Stone K (1993). Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci, 686, 12-27.
11. Schiffman MH, Haley NJ, Felton JS, et al (1987). Biochemical epidemiology of cervical neoplasia:measuring cigarette smoke constituents in the cervix. Cancer Res, 47, 3886-8.
12. Seeberg E, Eide L, Bjørås M (1995). The base excision repair pathway.Trends Biochem Sci, 20, 391-7.
13. Spitz M, Wei Q, Dong Q, et al (2003). Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev, 12, 689-98.
14. Settheetham-Ishida W, Singto Y, Yuenyao P, et al (2004). Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeast Thailand. Cancer Letters, 210, 205-11.
15. Settheetham-Ishida W, Kanjanavirojkul N, Kularbkaew C, Ishida T (2005). Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiol Immunol, 49, 417-21.
16. Settheetham-Ishida W, Yuenyao P, Kularbkaew C, et al (2009). Glutathione S-transferase (GSTM1 and GSTT1) polymorphisms in cervical cancer in Northeastern Thailand. Asian Pac J Cancer Prev, 10, 365-8.
17. Stern MC, Umbach DM, van Gils C, et al (2001). DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev, 10, 125-31.